 | | PRD_002455 | | Name: | D-PMI-omega | | Formula: | C82 H115 Cl N17 O20 | | Definition date: | 2021-11-17 | | Last modified: | 2021-11-17 |
|
 | | PRD_002454 | | Name: | Substrate-like cysteine protease inhibitor | | Formula: | C46 H70 Cl N10 O9 | | Definition date: | 2021-09-01 | | Last modified: | 2021-09-01 |
|
 | | PRD_002469 | | Name: | Inhibitor 18 | | Formula: | C30 H42 N4 O6 | | Definition date: | 2021-08-25 | | Last modified: | 2021-08-25 |
|
 | | PRD_002459 | | Name: | dodecyl 6-O-alpha-D-galactopyranosyl-beta-D-glucopyranoside | | Formula: | C24 H46 O11 | | Definition date: | 2021-08-04 | | Last modified: | 2021-08-04 |
|
 | | PRD_002457 | | Name: | beta-D-glucopyranose-(1-4)-beta-D-glucopyranose-(1-3)-2-deoxy-2-fluoro-alpha-D-glucopyranose | | Formula: | C18 H31 F O15 | | Definition date: | 2021-05-19 | | Last modified: | 2021-05-19 |
|
 | | PRD_002377 | | Name: | (12S,15S)-N-[(2-fluorophenyl)methyl]-10,13-dioxo-12-{2-oxo-2-[(2R)-2-phenylpyrrolidin-1-yl]ethyl}-2-oxa-11,14-diazatricyclo[15.2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-hexaene-15-carboxamide | | Formula: | C39 H39 F N4 O5 | | Definition date: | 2021-04-28 | | Last modified: | 2021-04-28 |
|
 | | PRD_002383 | | Name: | des4.3.1 | | Formula: | C44 H74 N12 O11 S | | Definition date: | 2021-04-28 | | Last modified: | 2021-04-28 |
|
 | | PRD_002362 | | Name: | GsIN-1 peptide | | Formula: | C79 H106 N16 O21 S | | Definition date: | 2021-04-21 | | Last modified: | 2021-04-21 |
|
 | | PRD_002397 | | Formula: | C41 H72 N14 O10 S | | Definition date: | 2021-03-31 | | Last modified: | 2021-03-31 |
|
 | | PRD_002398 | | Formula: | C42 H74 N14 O10 S | | Definition date: | 2021-03-31 | | Last modified: | 2021-03-31 |
|
 | | PRD_002399 | | Formula: | C45 H68 N10 O11 S | | Definition date: | 2021-03-31 | | Last modified: | 2021-03-31 |
|
 | | PRD_002360 | | Name: | myristoyl thiourea inhibitor, No. 23 | | Formula: | C37 H67 N9 O5 S | | Definition date: | 2021-03-24 | | Last modified: | 2021-03-24 |
|
 | | PRD_002361 | | Name: | myristoyl thiourea inhibitor, No.13 | | Formula: | C39 H73 N12 O5 S | | Definition date: | 2021-03-24 | | Last modified: | 2021-03-24 |
|
 | | PRD_002460 | | Formula: | C20 H39 N3 O5 | | Description: | Calpain I inhibitor | | Definition date: | 2021-02-24 | | Last modified: | 2021-02-24 |
|
 | | PRD_900134 | | Name: | Blood group B H type 2 antigen, beta anomer | | Formula: | C26 H45 N O20 | | Description: | oligosaccharide with branches | | Definition date: | 2021-02-17 | | Last modified: | 2021-02-17 |
|
 | | PRD_002447 | | Name: | (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide | | Formula: | C36 H55 N7 O6 | | Definition date: | 2020-10-07 | | Last modified: | 2020-10-14 |
|
 | | PRD_002452 | | Name: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate | | Formula: | C27 H40 Cl N3 O5 | | Definition date: | 2020-10-14 | | Last modified: | 2020-10-14 |
|
| | PRD_002448 | | Name: | (1S,3aR,6aS)-2-[(2S)-2-({(2S)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]octahydrocyclopenta[c]pyrrole-1-carboxamide | | Formula: | C36 H55 N7 O6 | | Definition date: | 2020-09-30 | | Last modified: | 2020-09-30 |
|
 | | PRD_002449 | | Name: | (ACE)(1MH)D(B3L)F(1U8) | | Formula: | C44 H54 N6 O12 | | Definition date: | 2020-09-30 | | Last modified: | 2020-09-30 |
|
 | | PRD_002450 | | Name: | (ACE)(1MH)D(PF5)F(1U8) | | Formula: | C46 H45 F5 N6 O12 | | Definition date: | 2020-09-30 | | Last modified: | 2020-09-30 |
|
 | | PRD_002372 | | Name: | ACE-VAL-ARG-MET-QZA | | Formula: | C22 H43 Cl N7 O5 S | | Definition date: | 2020-09-16 | | Last modified: | 2020-09-16 |
|
 | | PRD_002373 | | Name: | ACE-VAL-ARG-MET-B2A | | Formula: | C20 H41 B N7 O6 S | | Definition date: | 2020-09-16 | | Last modified: | 2020-09-16 |
|
 | | PRD_002352 | | Formula: | C22 H31 N3 O7 | | Definition date: | 2020-09-02 | | Last modified: | 2020-09-02 |
|
 | | PRD_002315 | | Name: | 4HP-PRO-LYS-ARG-NH2, BM-30 | | Formula: | C25 H42 N8 O5 | | Definition date: | 2020-08-26 | | Last modified: | 2020-08-26 |
|
 | | PRD_002267 | | Name: | D-Arg4,Leu10-Teixobactin | | Formula: | C59 H101 N14 O14 | | Definition date: | 2020-08-19 | | Last modified: | 2020-08-19 |
|
